Chugai Using Genedata's Screening Software in Tokyo Labs | GenomeWeb
NEW YORK (GenomeWeb News) — Genedata today said that Chugai Pharmaceuticals is using its Screener software to analyze high-throughput screening data.
 
Under the agreement, Genedata said its Tokyo-based staff has helped Chugai to integrate its AssayAnalyzer and Condoseo modules to review screening data and to evaluate compounds.
 
Genedata said Chugai has been using the software to help it develop drugs for cancer and for joint and bone diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.